Patrizia Di Iorio Selected Research

3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate

12/2019	Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells.
1/2019	Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrizia Di Iorio Research Topics

Disease

4	Neoplasms (Cancer) 12/2021 - 01/2018
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2007
3	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 09/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2007
2	Neuroblastoma 01/2021 - 01/2015
2	Glioma (Gliomas) 01/2017 - 11/2006
2	Hypoxia (Hypoxemia) 01/2017 - 02/2010
2	Brain Ischemia (Cerebral Ischemia) 02/2010 - 05/2007
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Insulin Resistance 12/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Wounds and Injuries (Trauma) 01/2019
1	Brain Injuries (Brain Injury) 01/2018
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2018
1	Brain Neoplasms (Brain Tumor) 09/2015
1	Ischemic Stroke 02/2013
1	Reperfusion Injury 02/2013
1	Hyperoxia 02/2010
1	Seizures (Absence Seizure) 09/2009
1	Absence Epilepsy (Childhood Absence Epilepsy) 09/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2008
1	Stroke (Strokes) 05/2007
1	Gliosis 09/2004

Drug/Important Bio-Agent (IBA)

6	GuanosineIBA 01/2021 - 11/2006
5	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 05/2007
4	PurinesIBA 01/2021 - 01/2018
4	EnzymesIBA 01/2021 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2007
2	GuanineIBA 01/2021 - 01/2018
2	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 12/2019 - 01/2019
2	purineIBA 01/2018 - 01/2017
2	Neuroprotective AgentsIBA 01/2015 - 11/2006
1	diethylstilbestrol monophosphate (PDES)IBA 12/2021
1	Cyclic NucleotidesIBA 12/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2021
1	Biological ProductsIBA 12/2021
1	Adenosine A1 ReceptorIBA 12/2021
1	LipidsIBA 01/2021
1	Adenine FDA LinkGeneric 01/2021
1	Kynurenic Acid (Kynurenate)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Purine NucleosidesIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Purinergic P2X7 ReceptorsIBA 12/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2019
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	NucleosidesIBA 01/2017
1	Purine-Nucleoside PhosphorylaseIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 09/2015
1	Purinergic Receptors (Receptors, Purine)IBA 09/2015
1	LigandsIBA 09/2015
1	Amyloid beta-PeptidesIBA 01/2015
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2015
1	Protons (Proton)IBA 02/2010
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2009
1	Glycogen Synthase Kinase 3 betaIBA 05/2007
1	Glutamic Acid (Glutamate)FDA Link 05/2007
1	CholesterolIBA 11/2006
1	Glial Fibrillary Acidic ProteinIBA 09/2004

Therapy/Procedure

2	Therapeutics 12/2021 - 09/2015
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2018
1	Thrombolytic Therapy 02/2013
1	Ligation 02/2010
1	Investigational Therapies (Experimental Therapy) 01/2007